SCHEMBL13633458

SCHEMBL13633458

Cc1ccc(S(=O)(=O)Nc2cc(Br)cc(CO)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ GAA P10253 2/20 0.48
▸ PKM P14618 1/20 0.46
▸ METAP2 P50579 1/20 0.45
▸ HSD11B1 P28845 2/20 0.45
▸ CYTH2 Q99418 1/20 0.43
▸ FFAR4 Q5NUL3 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ PDE4A P27815 1/20 0.42
▸ AGO2 Q9UKV8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13789387 0.88 KDM4E (0.50) KDM4EALDH1A1LMNAGAAPKM
SCHEMBL13749029 0.84 KDM4E (0.49) KDM4EALDH1A1LMNAGAAPKM
SCHEMBL13633538 0.79 METAP2 (0.54) KDM4EALDH1A1LMNAGAAPKM
SCHEMBL13633551 0.77 ALDH1A1 (0.53) KDM4EALDH1A1LMNAGAAPOLB
SCHEMBL13633501 0.73 KDM4E (0.58) KDM4EALDH1A1LMNAMETAP2FFAR4
SCHEMBL23089309 0.69 S1PR2 (0.38) KDM4EALDH1A1GAA
SCHEMBL14908004 0.69 KDM4E (0.68) KDM4EALDH1A1LMNAGAAPKM
SCHEMBL3146296 0.69 KDM4E (0.58) KDM4EALDH1A1LMNAHSD11B1FFAR4
SCHEMBL3006653 0.69 HSD11B1 (0.67) KDM4EALDH1A1LMNAHSD11B1MAPT
SCHEMBL2927789 0.69 ALDH1A1 (0.83) KDM4EALDH1A1LMNAMETAP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 — — US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 — — US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 — — US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191394-A1 Antibacterial agents MRPL21, RPN2, FBL KDM4E 4500/4885ALDH1A1 637/4885LMNA 2919/4885
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA KDM4E 4078/4885ALDH1A1 272/4885LMNA 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback